Bioprocessing Research Excellence Award (Sponsored by Solventum)

The Bioprocessing Research Excellence Award in Upstream & Downstream Processing (previously known as Young Professionals Award in Upstream and Downstream Processing), Sponsored by Solventum (formerly part of 3M) is annually awarded to early career professionals who present outstanding research in the field of bioprocessing within the Division of Biochemical Technology (BIOT) at the ACS National meeting. Starting from this year, two Awards will be presented annually: one for the best oral presentation, and one for the best poster presentation.

Please review the following eligibility criteria before applying for the award:

1. The applicant has up to 10 years of total professional experience as of March 2025,

and

2. The applicant is not currently a student (postdoctoral scholars are welcome to apply).

3. The research work should focus on Upstream & Downstream Processing

Please send us a copy of your poster/presentation or extended abstract to acsbiot.awards@gmail.com by March 20, 2025. If you cannot share a copy of your poster/presentation for the judges, an extended abstract of the proposed presentation is required. The extended abstract should be a maximum of three pages including text and figures/tables. This abstract should describe the research question(s) addressed in the presentation, the extent to which those questions will be answered, and the technological/scientific significance of the results. Indicate the publication status of this research at the time of application, including the journal and expected date of submission/publication.

The awardee will receive a cash award of $5,000 and a plaque to commemorate the award.

Eligible applicants must complete this form before Feb 28, 2025. (* refers to required questions)

If you have any questions, please contact acsbiot.awards@gmail.com.

Please click here to submit your nominations by February 28, 2025

Congratulations to the winners!

2024-2025 – Minjeong Cha for “In-silico purification developability assessment for monoclonal antibodies”